Friday, June 26, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $275.15 -6.12%
MSFT $352.83 -3.46%
GOOGL $343.71 -0.46%
AMZN $227.01 -3.10%
TSLA $375.12 -0.11%
META $542.87 -2.65%
NVDA $195.74 -1.64%
JPM $335.12 +0.50%
BTC $26.18 -1.10%
ETH $14.80 -1.60%
AAPL
$275.15
▼ 6.12%
MSFT
$352.83
▼ 3.46%
GOOGL
$343.71
▼ 0.46%
AMZN
$227.01
▼ 3.10%
TSLA
$375.12
▼ 0.11%
META
$542.87
▼ 2.65%
NVDA
$195.74
▼ 1.64%
JPM
$335.12
▲ 0.50%
Bloomberg Markets
UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the Trump administration is relaxing its previous hard-line stance on drug reviews.
business  Jun 17, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free